Home › Hodgkin Lymphoma › Washington
Hodgkin Lymphoma clinical trials in Washington, DC
4 studies for Hodgkin Lymphoma are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
RecruitingObservational study
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Tissue Collection for Studies of Lymph Cancer
RecruitingObservational study
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecruitingObservational study
- Children's National Medical Center, Washington D.C.
- Nih/Niaid, Bethesda · 7 mi away
- Nih/Nhlbi, Bethesda · 7 mi away
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
RecruitingPhase 1
- Children's National Medical Center, Washington D.C.
- National Cancer Institute, Pediatric Oncology Branch, Bethesda · 7 mi away
About Hodgkin Lymphoma
Hodgkin lymphoma is a type of lymphoma, cancer of the lymph system. It is serious but can usually be cured if found and treated early. Learn more.
More about Hodgkin Lymphoma on MedlinePlus
Hodgkin Lymphoma trials in other cities
- Houston, TX14 studies
- New York City, NY11 studies
- Boston, MA9 studies
- Baldwin Park, CA9 studies
- Miami, FL8 studies
- Memphis, TN7 studies
- Philadelphia, PA6 studies
- Atlanta, GA5 studies
- Mountain View, CA5 studies
- Greenburgh, NY5 studies
- Durham, NC4 studies
- Milwaukee, WI4 studies
Other studies in Washington
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer55 studies
- Breast Cancer46 studies
- Metastatic Cancer43 studies
- Lung Cancer41 studies
- Prostate Cancer38 studies
- Obesity33 studies
- Colorectal Cancer29 studies
- Cardiovascular Disease28 studies
- Bladder Cancer26 studies
- Acute Myeloid Leukemia24 studies
- Ovarian Cancer23 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.